Kevin Yeaman Sells 26,766 Shares of Dolby Laboratories (NYSE:DLB) Stock

Dolby Laboratories (NYSE:DLB) CEO Kevin Yeaman sold 26,766 shares of the business’s stock in a transaction on Tuesday, December 16th. The stock was sold at an average price of $66.74, for a total transaction of $1,786,362.84. Following the completion of the transaction, the chief executive officer owned 105,128 shares of the company’s stock, valued at approximately $7,016,242.72. This trade represents a 20.29% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Dolby Laboratories Price Performance

DLB opened at $66.74 on Friday. The stock has a market capitalization of $6.37 billion, a price-to-earnings ratio of 25.38 and a beta of 0.89. The business has a fifty day moving average price of $66.82 and a 200 day moving average price of $71.22. Dolby Laboratories has a 12 month low of $64.02 and a 12 month high of $89.66.

Dolby Laboratories (NYSE:DLB) last announced its quarterly earnings data on Tuesday, November 18th. The electronics maker reported $0.99 EPS for the quarter, topping analysts’ consensus estimates of $0.70 by $0.29. The business had revenue of $307.02 million during the quarter, compared to the consensus estimate of $305.76 million. Dolby Laboratories had a return on equity of 11.99% and a net margin of 18.90%.The business’s revenue for the quarter was up .7% on a year-over-year basis. During the same period in the previous year, the company posted $0.61 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. On average, research analysts anticipate that Dolby Laboratories will post 2.94 earnings per share for the current year.

Dolby Laboratories Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, December 10th. Investors of record on Tuesday, December 2nd were paid a dividend of $0.36 per share. The ex-dividend date was Tuesday, December 2nd. This is an increase from Dolby Laboratories’s previous quarterly dividend of $0.33. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.2%. Dolby Laboratories’s payout ratio is presently 54.75%.

Institutional Trading of Dolby Laboratories

Several institutional investors and hedge funds have recently made changes to their positions in the company. Allworth Financial LP grew its stake in Dolby Laboratories by 99.6% during the 3rd quarter. Allworth Financial LP now owns 1,006 shares of the electronics maker’s stock worth $73,000 after buying an additional 502 shares during the last quarter. Swiss Life Asset Management Ltd acquired a new stake in shares of Dolby Laboratories in the third quarter valued at approximately $210,000. Advisory Services Network LLC purchased a new position in shares of Dolby Laboratories during the third quarter worth approximately $102,000. XTX Topco Ltd acquired a new position in shares of Dolby Laboratories in the 3rd quarter valued at $741,000. Finally, Verition Fund Management LLC increased its holdings in shares of Dolby Laboratories by 172.4% in the 3rd quarter. Verition Fund Management LLC now owns 35,409 shares of the electronics maker’s stock valued at $2,563,000 after acquiring an additional 22,409 shares during the period. 58.56% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts have weighed in on the company. Wall Street Zen cut Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, November 22nd. Weiss Ratings reiterated a “hold (c-)” rating on shares of Dolby Laboratories in a report on Monday. Baird R W raised Dolby Laboratories to a “hold” rating in a research report on Friday, September 5th. Rosenblatt Securities decreased their target price on Dolby Laboratories from $95.00 to $85.00 and set a “buy” rating for the company in a research note on Wednesday, November 19th. Finally, Robert W. Baird began coverage on Dolby Laboratories in a report on Friday, September 5th. They issued a “neutral” rating and a $74.00 price target for the company. Three research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $92.00.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.